Jim Simons Immutep LTD Transaction History

Renaissance Technologies LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$3.09 - $4.81 $676,240 - $1.05 Million	-218,848 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$3.17 - $4.39 $405,851 - $562,047	128,029 Added 140.97%	218,848 $847,000
Q2 2021 Aug 13, 2021	SELL	$3.02 - $5.21 $411,870 - $710,545	-136,381 Reduced 60.03%	90,819 $351,000
Q1 2021 May 13, 2021	BUY	$2.37 - $3.68 $538,464 - $836,096	227,200 New	227,200 $698,000
Q4 2020 Feb 10, 2021	SELL	$1.64 - $5.69 $63,035 - $218,700	-38,436 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$1.05 - $1.89 $130,413 - $234,743	-124,203 Reduced 76.37%	38,436 $66,000
Q2 2020 Aug 13, 2020	SELL	$0.67 - $1.31 $117,015 - $228,791	-174,650 Reduced 51.78%	162,639 $176,000
Q1 2020 May 14, 2020	BUY	$0.72 - $3.03 $172,056 - $724,073	238,968 Added 243.05%	337,289 $243,000
Q4 2019 Feb 13, 2020	BUY	$1.6 - $1.9 $82,480 - $97,945	51,550 Added 110.22%	98,321 $176,000
Q3 2019 Nov 13, 2019	BUY	$1.27 - $1.78 $23,204 - $32,522	18,271 Added 64.11%	46,771 $75,000
Q2 2019 Aug 12, 2019	BUY	$1.74 - $2.16 $8,181 - $10,156	4,702 Added 19.76%	28,500 $52,000
Q1 2019 May 14, 2019	SELL	$1.97 - $2.57 $170,290 - $222,155	-86,442 Reduced 78.41%	23,798 $52,000
Q4 2018 Feb 13, 2019	BUY	$1.84 - $3.9 $202,841 - $429,936	110,240 New	110,240 $203,000

1.86M

264K

90.5K

Ticker IMMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,000
Market Cap $176M
Description
Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.